Jim Simons Vor Biopharma Inc. Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 701,431 shares of VOR stock, worth $140,286. This represents 0.0% of its overall portfolio holdings.
Number of Shares
701,431
Previous 529,500
32.47%
Holding current value
$140,286
Previous $587,000
13.97%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VOR
# of Institutions
45Shares Held
54.1MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA39.6MShares$7.93 Million0.59% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$1.27 Million3.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$388,0440.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$214,9310.26% of portfolio
-
Sarissa Capital Management LP Greenwich, CT508KShares$101,6030.1% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $7.61M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...